prognostic indicators

Research in Review

Colorectal Cancer Mortality Rates Reduced With Specific Type of Diet

05/09/2017

JCP Editors

Patients with colorectal cancer can decrease their risk of disease-related mortality by 54% if they consume certain types of food, according to a study presented at Digestive Disease Week (May 6-9, 2017; Chicago, IL;...

...

05/09/2017

Journal of Clinical Pathways

Research in Review

Older Patients With CLL Have Higher Risk of Disease-Related Mortality

05/04/2017

JCP Editors

Chronic lymphocytic leukemia (CLL)-related mortality is significantly higher in patients aged 75 years or older, prompting a need for novel treatment options, according to a study published in BMC Cancer...

...

05/04/2017

Journal of Clinical Pathways

Research in Review

Ovarian Cancer Survival Influenced By Previous Comorbidities

05/02/2017

JCP Editors

Common comorbidities such as hypertension, heart disease, and diabetes may contribute to a woman’s prognosis after being diagnosed with ovarian cancer, according to a study published in Cancer Causes Control...

Common...

05/02/2017

Journal of Clinical Pathways

Research in Review

PD-1 Expression in T-Cells Aids Immunotherapy Strategies for NSCLC

05/01/2017

JCP Editors

Early activation of programmed cell death-1 (PD-1) in CD8 T-cells after immunotherapy treatment is crucial to anti-tumor response for patients with non-small cell lung cancer (NSCLC), according to research published...

Early...

05/01/2017

Journal of Clinical Pathways

Research in Review

Combined Treatment Approach Improves Survival for Patients With Glioblastoma

04/03/2017

JCP Editors

A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...

A...

04/03/2017

Journal of Clinical Pathways

Research in Review

Hormonal Maintenance Therapy Improves PFS for Patients With Ovarian Cancer

03/21/2017

JCP Editors

Women with stage II-IV low-grade serous carcinoma of the ovary or peritoneum who received hormonal maintenance therapy after primary treatment had longer progression-free survival (PFS) compared with women who...

Women...

03/21/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Outcomes for Patients With CLL

03/10/2017

JCP Editors

The addition of a novel monoclonal antibody to ibrutinib significantly improves survival outcomes for patients with previously treated high-risk chronic lymphocytic leukemia (CLL), according to the results of a phase...

The...

03/10/2017

Journal of Clinical Pathways

Research in Review

Cetuximab Therapy for Anal Carcinoma Associated With Improved Outcomes, High Toxicity

03/03/2017

JCP Editors

Adding cetuximab to chemoradiation for squamous cell carcinoma of the anal canal is associated with lower incidence of locoregional failure but high toxicity, according to the results of a study published in the...

Adding...

03/03/2017

Journal of Clinical Pathways

Research in Review

Adding Androgens to Maintenance Therapy Improves Survival in Older Patients With AML

03/01/2017

JCP Editors

Maintenance therapy with androgens significantly improves survival in older patients with acute myeloid leukemia (AML) without increasing toxicity, according to research published in the Journal of Clinical Oncology...

...

03/01/2017

Journal of Clinical Pathways

Research in Review

Genetic Mutations May Be Used as Biomarkers for Relapsing CLL

02/24/2017

JCP Editors

Mutations in the BTK and PLCG2 genes have the potential to be used as a biomarker for relapse of chronic lymphocytic leukemia (CLL) after treatment with ibrutinib, according to a retrospective review published in the...

...

02/24/2017

Journal of Clinical Pathways